Kinjal Patel

Director, Global Risk Management

Professional Overview
Kinjal Patel is an accomplished risk management professional with over 10 years of experience in the pharmaceutical industry. As the Director of Global Risk Management at Bristol Myers Squibb, she oversees the development and implementation of comprehensive risk management strategies to ensure compliance, mitigate potential threats, and drive operational excellence across the organization.

Experience Summary

Current Role
Kinjal joined Bristol Myers Squibb in 2024 as the Director of Global Risk Management. In this role, she is responsible for leading a team of risk management specialists, developing and executing enterprise-wide risk assessment and mitigation plans, and collaborating with cross-functional stakeholders to embed a robust risk management culture throughout the company. Under her leadership, Bristol Myers Squibb has significantly improved its risk preparedness, enabling the organization to navigate complex regulatory environments and adapt swiftly to emerging challenges.

Career Progression
Prior to her current position, Kinjal held various risk management and pharmacovigilance roles, including Director of Pharmacovigilance at Arcus Biosciences and Director of Global Risk Management at NOVAVAX INC. Her earlier career experience also includes roles at Bristol Myers Squibb, where she progressed from Pharmacovigilance Scientist to Associate Director of Global Risk Management. Throughout her career, Kinjal has consistently demonstrated her ability to drive operational efficiencies, enhance risk management practices, and contribute to the long-term resilience of the organizations she has served.

Academic Background
Kinjal holds a Doctor of Pharmacy (Pharm.D.) degree from the University of the Sciences in Philadelphia, where she graduated with distinction. She also completed a Pharmacovigilance and Epidemiology Fellowship at Genzyme, further expanding her expertise in risk management and pharmaceutical safety.

Areas of Expertise

• Enterprise-wide risk assessment and mitigation

• Regulatory compliance and quality assurance

• Pharmacovigilance and drug safety monitoring

• Strategic planning and cross-functional collaboration

• Risk management policy development and implementation

• Data analysis and risk-informed decision-making

Professional Impact
During her tenure at NOVAVAX INC, Kinjal led the development and implementation of a comprehensive global risk management framework that significantly improved the company's ability to identify, assess, and respond to emerging risks. This initiative resulted in a 25% reduction in critical risk exposures and enhanced the organization's resilience during the COVID-19 pandemic. At Bristol Myers Squibb, Kinjal's contributions have been instrumental in strengthening the company's risk management practices, leading to improved operational efficiency, reduced regulatory penalties, and enhanced patient safety.

Conclusion
Kinjal Patel is a seasoned risk management professional with a proven track record of driving positive change and delivering tangible results in the pharmaceutical industry. Her expertise in risk assessment, regulatory compliance, and cross-functional collaboration, combined with her strategic mindset and strong leadership skills, make her a valuable asset to Bristol Myers Squibb as the organization navigates an ever-evolving risk landscape.